4//SEC Filing
Morgan Leigh 4
Accession 0000899243-23-015967
CIK 0001815442other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:15 PM ET
Size
5.4 KB
Accession
0000899243-23-015967
Insider Transaction Report
Form 4
Morgan Leigh
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-15+12,000→ 12,000 totalExercise: $27.67Exp: 2033-06-14→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2024 and (ii) the date of the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001935887
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:15 PM ET
- Size
- 5.4 KB